毕得医药：已回购181.78万股 使用资金总额8203.1万元

Core Viewpoint - The company announced a share repurchase plan, indicating confidence in its financial health and future prospects [1] Summary by Relevant Sections Share Repurchase Details - The company repurchased a total of 1.8178 million shares from February 24, 2025, to August 23, 2025, which represents 2.00% of its total share capital [1] - The repurchase price ranged from 37.47 yuan per share to 53.3 yuan per share [1] - A total of 82.031 million yuan was used for the repurchase, excluding transaction fees [1] Compliance and Regulations - The repurchase was conducted in accordance with relevant laws and regulations, as well as the company's repurchase plan [1]